Amantadine treatment following traumatic brain injury in children

References

• Rutland-Brown W, Langlois LA, Thomas KE, Xi L. Incidence of traumatic brain injury in the United States, 2003. Journal of Head Trauma Rehabilitation 2006; 21: 544–548
   PubMed Web of Science ®Google Scholar
• Berney J, Favier J, Froidevaux AC. Paediatric head trauma: Influence of age and sex. Child's Nervous System 1994; 10: 509–516
   PubMed Web of Science ®Google Scholar
• Frankowski KF, Annegers JF, Whitman S. Epidemiological and descriptive studies. Part 1: The descriptive epidemiology of head trauma in the United States. Central nervous system trauma status report–1985, JT Povlishck, DP Becker. National Institute of Health, Washington, DC 1985; 33–43
   Google Scholar
• Yeates KO. Closed head injury. Pediatric neuropsychology: Research, theory and practice, KO Yeates, MD Ris, HG Taylor. Guilford Press, New York 1999; 92–116
   Google Scholar
• Bates G. Medication in the treatment of behavioural sequelae of traumatic brain injury. Developmental Medicine and Child Neurology 2006; 48: 697–701
   PubMed Web of Science ®Google Scholar
• Gualtieri CT. Pharmacotherapy and the neurobehavioral sequelae of traumatic brain injury. Brain Injury 1988; 2: 101–129
   PubMedGoogle Scholar
• Whyte J, Hart T, Schuster K, Fleming M, Plansky M, Coslett HB. Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebo-controlled trial. American Journal of Physical Medicine and Rehabilitation 1997; 6: 440–450
   Web of Science ®Google Scholar
• Williams SE, Ris MD, Ayyangar R, Schefft BK, Berch D. Recovery in pediatric head injury: Is psychostimulant medication beneficial?. Journal of Head Injury Rehabilitation 1998; 13: 73–81
   PubMed Web of Science ®Google Scholar
• Jin C, Schachar R. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: A critical appraisal of treatment studies. Central Nervous System Spectrums 2004; 9: 217–226
   Google Scholar
• Aoki F, Sitar D. Clinical pharmacokinetics of amantadine-hydrochloride. Clinical Pharmacokinetics 1988; 14: 35–51
   PubMed Web of Science ®Google Scholar
• Kraus MF, Maki PM. Effect of amantadine on symptoms of frontal lobe dysfunction in brain injury: Case studies and review. Journal of Neuropsychiatry 1997; 9: 222–230
   PubMed Web of Science ®Google Scholar
• Schwab RS, England AC, Psokanzer DC, Young RR. Amandatine in the treatment of Parkinson's disease. Journal of the American Medical Association 1969; 208: 1168–1170
   PubMed Web of Science ®Google Scholar
• Chandler MC, Barnhill JL, Gualtieri CT. Amantadine for the agitated head-injury patient. Brain Injury 1988; 2: 309–311
   PubMedGoogle Scholar
• Gualtieri CT, Chandler M, Coons TB, Brown LT. Amantadine: A new clinical profile for traumatic brain injury. Clinical Neuropharmacology 1989; 12: 258–270
   PubMed Web of Science ®Google Scholar
• Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury: A pilot double-blind randomized trial. Journal of Head Trauma Rehabilitation 2002; 17: 300–313
   PubMed Web of Science ®Google Scholar
• Napolitano E, Elovic EP, Qureshi AI. Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury. Medical Science Monitor 2005; 11: RA212–RA220
   PubMed Web of Science ®Google Scholar
• Wu TS, Garmel GM. Improved neurological function after amantadine treatment in two patients with brain injury. The Journal of Emergency Medicine 2005; 28: 289–292
   PubMed Web of Science ®Google Scholar
• Leone H, Polsonetti BW. Amantadine for traumatic brain injury: Does it improve cognition and reduce agitation?. Journal of Clinical Pharmacological Therapy 2005; 30: 101–104
   PubMed Web of Science ®Google Scholar
• Hughes S, Colantonio A, Santaguida PL, Paton T. Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Injury 2005; 19: 1197–1206
   PubMed Web of Science ®Google Scholar
• Beers SR, Skold A, Dixon CE, Adelson PD. Neurobehavioral effects of amantadine after pediatric traumatic brain injury: A preliminary report. Journal of Head Trauma Rehabilitation 2005; 20: 450–463
   PubMed Web of Science ®Google Scholar
• Edby K, Larsson J, Eek M, von Wendt L, Ostergard B. Amantadine treatment of a patient with anoxic brain injury. Child Nervous System 1995; 11: 607–609
   PubMed Web of Science ®Google Scholar
• Green LB, Hornyak JE, Hurvitz AE. Amantadine in pediatric patients with traumatic brain injury. American Journal of Physical Medicine and Rehabilitation 2004; 83: 893–897
   PubMed Web of Science ®Google Scholar
• Patrick PD, Buck ML, Conaway MR, Blackman JA. The use of dopamine enhancing medications with children with low response states following brain injury. Brain Injury 2003; 17: 497–506
   PubMed Web of Science ®Google Scholar
• Patrick PD, Blackman JA, Mabry JL, Buck ML, Gurka MJ, Conaway MR. Dopamine agonist therapy in low-response children following traumatic brain injury. Journal of Child Neurology 2006; 21: 879–885
   PubMed Web of Science ®Google Scholar
• Arciniegas DB, Held K, Wagner P. Cognitive impairment following traumatic brain injury. Current Treatment Options in Neurology 2002; 4: 43–57
   PubMedGoogle Scholar
• Schneider WN, Drew-Cates J, Wong TM, Dombovy ML. Cognitive and behavioral efficacy of amantadine in acute traumatic brain injury: An initial double-blind placebo-controlled study. Brain Injury 1999; 13: 863–872
   PubMed Web of Science ®Google Scholar
• Whyte J. Treatments to enhance recovery from vegetative and minimally conscious states: Ethical issues surrounding efficacy studies. American Journal of Physical Medicine and Rehabilitation 2007; 86: 86–92
   PubMed Web of Science ®Google Scholar